A Study of MHB036C Combined With MHB039A in Patients With Advanced Breast Cancer or Other Advanced Malignant Solid Tumors
Clinical trial NCT07130383 · RECRUITING
Trial details
- NCT number
- NCT07130383
- Sponsor
- Minghui Pharmaceutical (Hangzhou) Ltd
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-30
- Primary completion
- 2029-08-01
- Enrollment
- 210
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.